1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Meridian Bioscience, Inc. (VIVO) - Product Pipeline Analysis, 2016 Update

Summary

Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. Meridian develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. It has o several diagnostic tests and transport media, spanning from prenatal care, respiratory infections, and organ transplant infections among other infectious disease areas. Meridian offers its products to hospitals, clinics, veterinary testing centers, reference laboratories, research centers, physician offices and diagnostics manufacturers. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Ohio, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Meridian Bioscience, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Meridian Bioscience, Inc. (VIVO) - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Meridian Bioscience, Inc. Company Snapshot 5
Meridian Bioscience, Inc. Company Overview 5
Key Information 5
Meridian Bioscience, Inc. Pipeline Products and Clinical Trials Overview 6
Meridian Bioscience, Inc. - Pipeline Analysis Overview 8
Business Description 8
Meridian Bioscience, Inc. - Major Products and Services 9
Meridian Bioscience, Inc. Pipeline Products by Development Stage 12
Meridian Bioscience, Inc. Pipeline Products Overview 13
Illumigene E. coli Assay 13
Illumigene E. coli Assay Product Overview 13
Illumigene Giardia Assay 14
Illumigene Giardia Assay Product Overview 14
POC Disease Detection Device 15
POC Disease Detection Device Product Overview 15
Meridian Bioscience, Inc. - Key Competitors 16
Meridian Bioscience, Inc. - Key Employees 17
Meridian Bioscience, Inc. - Key Employee Biographies 18
Meridian Bioscience, Inc. - Locations And Subsidiaries 19
Head Office 19
Other Locations and Subsidiaries 19
Recent Developments 21
Meridian Bioscience, Inc., Recent Developments 21
Jan 26, 2016: Meridian Bioscience and Lean Continuous Improvements, Collaborate to Apply Lean Principles to Recent Launch of illumigene Malaria 21
Jan 26, 2016: Meridian Bioscience and Lean Continuous Improvements Collaborate to Apply Lean Principles to Recent Launch of illumigene Malaria 21
Jan 26, 2016: New Malaria Test, illumigene Malaria, Sets a New Gold Standard for Diagnosis 22
Dec 09, 2015: Bioline Launches New JetSeq DNA Library Preparation Kit 23
Nov 18, 2015: Meridian Receives FDA Clearance For New Molecular Whooping Cough Test Claims 23
Nov 05, 2015: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance 24
Sep 09, 2015: Meridian Bioscience Provides Net Revenues and Earnings Guidance for Fiscal 2016 25
Sep 04, 2015: BioLineRx Launches New EPIK miRNA Panel Assays 25
Aug 17, 2015: Meridian Bioscience Elects Catherine Sazdanoff and John McIlwraith to the Board of Directors 26
Jul 23, 2015: Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance 26
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Meridian Bioscience, Inc., Key Facts 5
Meridian Bioscience, Inc. Pipeline Products and Clinical Trials Overview 6
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 6
Meridian Bioscience, Inc. Pipeline Products by Indication 7
Meridian Bioscience, Inc., Major Products and Services 9
Meridian Bioscience, Inc. Number of Pipeline Products by Development Stage 12
Meridian Bioscience, Inc. Pipeline Products Summary by Development Stage 12
Illumigene E. coli Assay - Product Status 13
Illumigene E. coli Assay - Product Description 13
Illumigene Giardia Assay - Product Status 14
Illumigene Giardia Assay - Product Description 14
POC Disease Detection Device - Product Status 15
POC Disease Detection Device - Product Description 15
Meridian Bioscience, Inc., Key Employees 17
Meridian Bioscience, Inc., Key Employee Biographies 18
Meridian Bioscience, Inc., Other Locations 19
Meridian Bioscience, Inc., Subsidiaries 19

List of Figures
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 7
Meridian Bioscience, Inc. Pipeline Products by Development Stage 12

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016 Summary Global Markets ...

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) ...

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘N-Formyl ...


Download Unlimited Documents from Trusted Public Sources

Healthcare Industry - Analyst Report, December 2016

  • December 2016
    15 pages
  • Hepatitis C  

  • India  

    World  

View report >

TiGenix NV - Company Report, December 2016

  • December 2016
    53 pages
  • Digestive Syste...  

    Blood Disease  

  • Europe  

    United States  

View report >

GSK - Company Report, November 2016

  • November 2016
    90 pages
  • Vaccine  

    Infectious Dise...  

  • World  

    United Kingdom  

    Europe  

View report >

Related Market Segments :

Infectious Disease

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.